The aim is to assess the impact of chronic inflammatory demyelinating polyneuropathy on health-related quality of life and the role of treating depression.
Evaluated health-related quality of life in patients with CIDP
Investigated the effects of adjunct treatment for depression on quality of life
Conducted assessments of physical and mental health components
Health-related quality of life is significantly reduced in CIDP patients
Adjunct treatment of depression shows promising effects on improving quality of life
Encouragement for further therapeutic strategies targeting both CIDP and depression
Abstract
HRQoL is reduced in CIDP patients. Adjunct treatment of depression shows encouraging potential as a therapeutic approach to enhance HRQoL.